Breakthrough Designation Can Be 'Lever' For Drug Manufacturing Evolution, US FDA Says
This article was originally published in SRA
The US Food and Drug Administration's breakthrough therapies program has been lauded for helping get game-changing drugs to market faster. In the process it also may help industry modernize its manufacturing systems.
Register for our free email digests: